Ayala Pharmaceuticals Inc. revenue growth has been varied year-over-year.

What is ADXS's revenue growth rate?

Historical revenue data is available for Ayala Pharmaceuticals Inc. to analyze growth trends.

How fast is ADXS earnings growing?

Earnings growth data is available for Ayala Pharmaceuticals Inc. analysis.

What is ADXS's profit margin?

Profit margin data is available for Ayala Pharmaceuticals Inc. .

ADXS Revenue & Earnings Growth Analysis 2026 - Is Ayala Pharmaceuticals Inc. Growing?

Growth Summary

Ayala Pharmaceuticals Inc. (ADXS) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.

Over the past 4 years, Ayala Pharmaceuticals Inc. has achieved a revenue compound annual growth rate (CAGR) of -52.4%, while earnings have grown at 16.1% CAGR.

Latest Revenue

$13.00K

Net Income

$-48072000.00

5-Year Revenue CAGR

-52.4%

4 years of data

Net Margin

N/A

Latest period

Revenue Growth Over Time

Historical revenue and profitability trends for Ayala Pharmaceuticals Inc.

The chart above illustrates Ayala Pharmaceuticals Inc. 's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Growth rates provide insight into the momentum of Ayala Pharmaceuticals Inc. 's business.

Profit Margin Trends

How efficiently Ayala Pharmaceuticals Inc. converts revenue into profit

Understanding Profit Margins

Profit margins reveal how much of each dollar of revenue Ayala Pharmaceuticals Inc. retains at different stages:

Gross Margin (N/A%): What remains after direct production costs
Operating Margin (N/A%): Profit from core operations before interest and taxes
Net Margin (N/A%): Final profit after all expenses

Future Growth Outlook

Analyst estimates and forward-looking indicators

Price Target

$4.00

Analyst consensus

What Analysts Are Saying

Wall Street analysts project Ayala Pharmaceuticals Inc. to continue focusing on sustainable operations.

Growth Analysis Conclusion

Based on our comprehensive analysis, Ayala Pharmaceuticals Inc. (ADXS) demonstrates declining growth characteristics.

Key Takeaways:

Revenue Growth:, -52.4% CAGR over 4 years
Profitability: shows the company is investing in growth over short-term profits
Efficiency:

Investment Considerations

This growth analysis provides a comprehensive view of Ayala Pharmaceuticals Inc. 's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.